VEXAS syndrome is a rare adult-onset inflammatory disease linked to bone-marrow mutations. Doctors explain why it is often ...
inews.co.uk on MSN
I've got the breast cancer gene but had to wait three years for surgery
Thousands of women with a cancer-causing genetic mutation are facing an agonising wait for a mastectomy, due to a backlog ...
Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.
Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...
Opinion
19hOpinion
What’s in a club DNA? Alonso exit shows the only reliable predictors of success are wealth and good decisions
Real Madrid and Manchester United put their faith in familiarity but the lesson of Ferguson is dynastic greatness rests not in tradition but ditching principles ...
The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug ​for children ...
The Orissa High Court has held that a writ petition seeking deletion of deceased person's name from Record of Rights (RoR) ...
The FDA has approved Zycubo (copper histidinate) injection as the first and only treatment of Menkes disease in pediatric ...
Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.
MACH Engineering reports factory air emissions harm health, environment, and businesses. Controlling emissions is vital for ...
Study supports favorable safety and tolerability profile and clinically meaningful functional and structural benefits in ...
In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying e ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback